Table 1 Characteristic and clinical profiles of the study subjects
|  | High YZ score (n = 583) | Low YZ score (n = 438) | p-value |
|---|---|---|---|
Mean age (years) | 61.3 ± 11.4 | 59.7 ± 10.5 | 0.020* |
Male (%) | 46.5 | 52.7 | 0.048* |
Diabetes duration (years) | 11.9 ± 7.4 | 10.8 ± 6.8 | 0.017* |
Hypertension ratio (%) | 73.9 | 79 | 0.060 |
Current smoking (%) | 18.3 | 18.0 | 0.917 |
Body mass index (kg/m2) | 25.6 ± 4.0 | 25.7 ± 3.5 | 0.722 |
Fasting plasma glucose (mmol/L) | 8.0 ± 2.5 | 7.9 ± 2.3 | 0.590 |
Hemoglobin A1c % | 8.0 ± 1.5 | 7.8 ± 1.4 | 0.015* |
Total cholesterol (mmol/L) | 4.9 ± 1.1 | 4.9 ± 1.0 | 0.845 |
Triglycerides (mmol/L) | 1.9 ± 1.6 | 1.8 ± 1.3 | 0.322 |
HDL cholesterol (mmol/L) | 1.2 ± 0.4 | 1.3 ± 0.4 | 0.181 |
LDL cholesterol (mmol/L) | 3.1 ± 1.0 | 3.1 ± 0.9 | 0.912 |
hs-CRP (mg/L) | 3.1 ± 6.5 | 3.0 ± 10.4 | 0.899 |
Creatinine (μmol/L) | 80.4 ± 61.9 | 79.2 ± 47.4 | 0.747 |
Uric acid (μmol/L) | 374.9 ± 113.1 | 374.9 ± 101.2 | 0.888 |
Normoalbuminuria (%) | 56.7 | 61.6 | 0.101 |
Microalbuminuria (%) | 28.7 | 28.0 | |
Macroalbuminuria (%) | 14.6 | 10.3 |